Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.21.2
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Beginning balance, value at Dec. 31, 2019 $ 6,157,565 $ 6,467 $ 198,975,056 $ (192,823,958)  
Beginning balance, shares at Dec. 31, 2019   64,672,893      
Issuance of common stock, net of issuance costs 114,562,242 $ 1,728 114,560,514    
Issuance of common stock, net of issuance costs, shares   17,284,934      
Stock-based compensation expense 10,116,775   10,116,775    
Issuance of common stock upon exercise of stock options 574,233 $ 25 574,208    
Issuance of common stock upon exercise of stock options, shares   249,578      
Fair Value of warrant issued in connetion with K2HV 472,409   472,409    
Unrealized gain (loss) on marketable debt securities        
Net loss (102,657,472)     (102,657,472)  
Ending balance, value at Sep. 30, 2020 29,225,752 $ 8,220 324,698,962 (295,481,430)  
Ending balance, shares at Sep. 30, 2020   82,207,405      
Beginning balance, value at Jun. 30, 2020 48,413,879 $ 8,065 308,991,895 (260,586,081)  
Beginning balance, shares at Jun. 30, 2020   80,655,848      
Issuance of common stock, net of issuance costs 11,331,889 $ 150 11,331,739    
Issuance of common stock, net of issuance costs, shares   1,504,473      
Stock-based compensation expense 3,630,996   3,630,996    
Issuance of common stock upon exercise of stock options 271,928 $ 5 271,923    
Issuance of common stock upon exercise of stock options, shares   47,084      
Fair Value of warrant issued in connetion with K2HV 472,409   472,409    
Unrealized gain (loss) on marketable debt securities        
Net loss (34,895,349)     (34,895,349)  
Ending balance, value at Sep. 30, 2020 29,225,752 $ 8,220 324,698,962 (295,481,430)  
Ending balance, shares at Sep. 30, 2020   82,207,405      
Beginning balance, value at Dec. 31, 2020 45,274,925 $ 9,885 349,358,378 (304,093,338)  
Beginning balance, shares at Dec. 31, 2020   98,852,696      
Issuance of common stock, net of issuance costs 59,110,801 $ 2,554 59,108,247    
Issuance of common stock, net of issuance costs, shares   25,539,585      
Stock-based compensation expense 7,686,921   7,686,921    
Issuance of common stock upon exercise of stock options $ 944,799 $ 84 944,715    
Issuance of common stock upon exercise of stock options, shares 838,600 838,600      
Unrealized gain (loss) on marketable debt securities $ (8,967)       $ (8,967)
Net loss (35,379,693)     (35,379,693)  
Ending balance, value at Sep. 30, 2021 77,628,786 $ 12,523 417,098,261 (339,473,031) (8,967)
Ending balance, shares at Sep. 30, 2021   125,230,881      
Beginning balance, value at Jun. 30, 2021 76,959,201 $ 12,508 414,249,029 (337,296,882) (5,454)
Beginning balance, shares at Jun. 30, 2021   125,083,006      
Issuance of common stock, net of issuance costs 250,000 $ 15 249,985    
Issuance of common stock, net of issuance costs, shares   147,875      
Stock-based compensation expense 2,599,247   2,599,247    
Unrealized gain (loss) on marketable debt securities (3,513)       (3,513)
Net loss (2,176,149)     (2,176,149)  
Ending balance, value at Sep. 30, 2021 $ 77,628,786 $ 12,523 $ 417,098,261 $ (339,473,031) $ (8,967)
Ending balance, shares at Sep. 30, 2021   125,230,881